AIM movers: Impax Asset Management AUM declines and Union Jack Oil drilling another US well

1

Biotech Sareum (LON: SAR) co-founder and chief executive Tim Mitchell is transitioning to the part-time role of chief operating officer. Dr Stephen Parker becomes executive chairman. The share price improved 7.94% to 34p.

Capital Metals (LON: CMET) has received consents so that drilling can commence at the Eastern Minerals project in Sri Lanka. The focus will be resource extension and confirming the resource. The minimum target is to double the existing resource of 17.2Mt at 17.6% total heavy minerals. The share price is 7.35% ahead at 1.825p.

Union Jack Oil (LON: UJO) has spudded the Andrews 2-17 well in Oklahoma, where it has a 45% interest. The Andrews 1-17 well is already in production. The Wressle project in the UK has generated $1m of revenues since the end of April. The share price is 6.45% higher at 16.5p.

CleanTech Lithium (LON: CTL) expects to hear from the Chilean government about its expression of interest relating to the Laguna Verde and Viento Andino projects and three other joint ventures by the end of August. The share price rose 5.08% to 15.5p.

Pit optimisations at the Dokwe gold project in Zimbabwe, recently acquired by Ariana Resources (LON: AAU), have increased measured and indicated resources by 16%. Dokwe could produce 75,000-100,000 ounces of gold/year for more than a decade. A revised pre-feasibility study should be published in a few months. The previous study suggested a post-tax NPV10 of $160m. The share price improved 4.65% to 2.25p.

Quadrise (LON: QED) says that trials of its lower emissions MSAR and bioMSAR fuels for marine vessel the MSC Leandra have not started yet. In February, Quadrise announced a collaboration agreement with Cargill and MAC2 Solutions, but the full agreement has not been signed. Cargill will supply feedstocks and MAC2 provide jetty space. Cargill has a fleet of more than 500 vessels. The share price recovered 3.63% to 2.0725p.

FALLERS

UK Oil & Gas (LON: UKOG) has raised £500,000 at 0.015p/share. This will repay the convertible funding facility with RiverFort Global Opportunities and YA II PN. The remaining cash will fund hydrogen storage projects. the share price slumped 21.4% to 0.0165p.

Impax Asset Management (LON: IPX) reported a 7% fall in asset under management to £36.9bn in the quarter to June 2024. That is a 1.3% decline over nine months. There was a net outflow of £1.89bn in the quarter and the rest of the decline was negative performance. It appears that some investors are still reducing exposure to equities. The 2023-24 earnings forecast has been cut by 3% to 29.7p/share. Impax Asset Management is acquiring the European fixed income operations of SKY Harbor Capital Management, which covers assets under management of $2bn. The acquisition of Copenhagen-based Absalon Capital Management should be completed soon. The share price declined 9.47% to 377.5p.

Lithium explorer Atlantic Lithium (LON: ALL) says an investigation has commenced following the death of a worker at the Ewoyaa project in Ghana. Activities have been suspended. The share price dipped 5.45% to 18.91p.

Petro Matad has multi-bagger potential in the run-up to production in Mongolia

Those with good memories will remember the fanfare surrounding Petro Matad when it first discovered oil in Mongolia in 2010. Petro Matad made a series of discoveries that made it one of the most exciting London-listed exploration companies of the time.

Recent developments for the company are reigniting this excitement, and rightly so. Brokers’ price targets suggest Petro Matad shares could appreciate multiples of the current price, and there is now a solid foundation for them to do so.

UK Investor Magazine published ‘Four UK Small Cap Growth Shares to Watch Summer 2024’ just before the announcement of a material development for Petro Matad in late June. Should timings have been different, this selection would likely be Five stocks and include Petro Matad.

The company has been substantially derisked as an investment for new investors after raising $8.9m by way of a placing in late June. The funds will be used almost exclusively to take Petro Matad’s Heron project through to production in 2024/25, a milestone that will unlock substantial shareholder value.

However, it has not been plane sailing for Petro Matad, and many investors may have only recently considered the stock after a heavily discounted placing.

In 2010-2012, the Mongolian natural resources sector was in the limelight. Rio Tinto was developing the world’s largest copper deposit at the Olu Tolgoi copper mine, capturing the attention of global investors and Mongolia was opening up to overseas investors.

Petro Matad rode this wave for a short period as evaluation of its assets revealed the extent of the resources in place at its Block XX field. The excitement around the quality of oil in place was replaced by frustrations at the Mongolian bureaucracy, and Petro Matad shares suffered dearly. Early investors were left licking their wounds.

Fast forward past numerous hurdles and bumps in the road, a ruling by the Mongolian government to certify Block XX and the Heron discovery as special purpose land in 2023 represented a step change in the authorities approach. A land usage agreement signed in early 2024 has paved the way for production to begin. 

Production from Petro Matad’s assets has been a long time coming. The first production-sharing agreement with the Mongolian government was signed nearly 20 years ago, in 2005. The Petro Matad saga should serve as a lesson to natural resource investors about just how long it takes for the production of promising assets to begin. 

With approvals and licensing agreements seemingly mostly complete, Petro Matad now has a clear path to production and the opportunity for share price appreciation.

Early production at the Heron project is expected to help support exploration, evaluation and eventual production across the rest of the Heron prospect, and the Gobi Bear prospect. The company has a 5-year plan to reach production of 9,000 barrels of oil per day.

In addition to oil production, Petro Matad is harnessing Mongolia’s landscape for renewable energy generation through a JV with SunSteppe, which already has a battery storage system and a green hydrogen project powered by wind power underway. Petro Matad’s transition to an oil producer and clean energy producer will provide diversification and potential revenue streams long into the future.

Broker targets

Zeus has a price target based on a Core NAV of 4.3p, rising to 28.7p for Total Unrisked NAV. The greater of these two price targets represents substantial upside to the current share price of 2.8p.

The Zeus price target, as with most broker price targets for AIM companies, should be taken with two shovels of salt. That said, it does provide some scale of where Petro Matad shares could go in the medium term.

For context, much of the Total Unrisked NAV valuation (17.9p of 28.7p) is derived from further exploration of the Saiga and Gobi Bear projects in Block XX. Zeus’s price target does not include the renewable JV.

Market conditions

The market conditions for early-stage natural resources companies favour Petro Matad. There has been a notable uptick in interest in the sector in recent months, and several companies have yielded investors very respectable returns, especially in speculative Helium-related plays. One would expect some of this cash to find its way into Petro Matad as the fast money spins into the next opportunity.

But this isn’t just a short-term play. The company says it expects the recent fundraise to take it through to production at Heron. This means cash flows and, very likely, further shareholder value creation through the evaluation of prospects in Block XX.

We must note, Petro Matad doesn’t come without potential operational setbacks that could pose a risk to the share price.

Barratt Developments sees further slow down in completions next year

Barratt Developments, one of the UK’s largest housebuilders, reported a mixed performance for the financial year 2024, reflecting the ongoing challenges in the housing market caused by high interest rates and the cost-of-living crisis.

Indeed, the word ‘challenging’ was used twice in the company’s outlook. Investors will hope the new Labour government acts quickly to improve conditions for builders.

The company saw a slight improvement in its net private reservation rate, which rose to 0.58 per active outlet per week, up from 0.55 in the previous year. This 5.5% increase was partly bolstered by sales to the private rental sector and registered providers of social housing.

However, total home completions fell significantly to 14,004, an 18.6% decrease from the 17,206 reported in FY23. The decline was more pronounced in the first half of the year, with a 28.5% drop, while the second half saw a more modest 8.7% reduction.

The average selling price also saw a downturn, with the total ASP falling to approximately £307,000, compared to £319,600 in the previous year. The private ASP experienced a more substantial decrease of 6.4%, dropping to about £344,000.

Despite these challenges, Barratt’s forward sales position remained relatively stable. As of 30 June 2024, the company reported total forward sales of £1,912.3 million, representing 7,239 homes. This is down from £2,223.4 million and 8,995 homes at the same point last year.

Looking ahead, Barratt anticipates a further reduction in completions for FY25, projecting between 13,000 to 13,500 homes. The company attributes this to lower land buying activity in recent years and a forecasted 9% reduction in average sales outlets for the coming year.

Barratt’s problems were summed up by its CEO’s comments, who chose to focus on build quality and the balance sheet amid a slowdown in completions, which will concern some investors.

“Whilst we continue to navigate a challenging macroeconomic backdrop, we are delivering industry leading build quality, sustainability and customer service. Combined with the strength of our balance sheet, this has ensured we remain resilient and responsive through the cycle,” said David Thomas, Chief Executive.

Diversified Energy acquires eastern Texas gas assets

Diversified Energy Company PLC has announced the acquisition of high-value natural gas assets from Crescent Pass Energy for £84 million ($106 million).

The deal, expected to close in Q3 2024, will bolster Diversified’s presence in eastern Texas with 827 net operated wells and over 170,000 acres of commercially attractive leasehold.

Funding for the acquisition comes from a mix of sources. Diversified will harness its NYSE listing to issue approximately 2.4 million new US dollar-denominated ordinary shares directly to the seller. The remainder will be financed through a senior secured bank facility and existing liquidity.

The purchase price represents a PV-20 valuation, signalling Diversified’s confidence in the assets’ long-term value. At £2,100 ($2,651) per flowing Mcfe, the deal is attractively priced within the company’s target range.

Current net production from the assets stands at 38 MMcfepd, with low annual declines of around 9%. This aligns well with Diversified’s strategy of acquiring stable, long-life assets. Estimated next twelve months EBITDA of £20.6 million ($26 million) represents a 3.8x purchase multiple.

“The target assets are a perfect fit with our existing East Texas operations and offer meaningful opportunities for cost efficiencies upon completion of the Acquisition,” said CEO Rusty Hutson, Jr.

“The accretive transaction adds scale to our Central region footprint and remains consistent with our strategy to focus on high-quality, low-decline producing assets at attractive PV values where we can apply our Smarter Asset Management approach to enhance margins and grow free cash flow.

“The evolution of our funding sources, illustrated by the use of direct equity issuance to the seller as a portion of the consideration, highlights the importance of our recent NYSE listing while providing additional financial flexibility. Our Company has a long-standing, demonstrated track record of delivering value to shareholders from our strategy of acquiring, optimizing, and managing mature producing assets, making us the Right Company at the Right Time.”

Putting the past behind it

Some AIM-quoted companies have strong underlying businesses with good prospects that are masked by past mistakes, not always made by the current management team. This can hold back the share price for years.  
They can drag on and be a drain on cash resources, but when they are finally sorted out it can leave an undervalued share price unappreciated by investors. Thus, providing a buying opportunity.  
Provisions
Property, electrical and energy efficiency services provider Kinovo (LON: KINO) has been dogged by problems relating to the disposal of former subsidiary DCB following the c...

The FTSE 100 treads water in defensive trade as BP disappoints

After a bump higher following the elections last week, the FTSE 100 paused on Tuesday as the index traded around breakeven with a clear interest in defensive sectors.

Severn Trent, United Utilities, National Grid and gold miner Endeavour were among the top gainers as investors favoured those companies with ‘safer’ attributes.

“The FTSE 100 closed broadly flat yesterday and has opened today in a similar fashion, without too many catalysts to drive a move either way. Housing sector investors welcomed Rachel Reeve’s speech yesterday and new supply pledges helped a slew of listed builders tick higher,” said Matt Britzman, senior equity analyst, Hargreaves Lansdown.

The housebuilders have provided support for the index in recent sessions, but the buying pressure started to ebb on Tuesday after Vistry released a positive trading update that didn’t wow investors.

Vistry shares slipped in early trade but picked up as the session progressed, although housebuilders Persimmon, Taylor Wimpey, and Barratts remained fairly static.

An update from BP provided the biggest counterweight to buying activity in defensive stocks. The company said production is fairly flat, and lower oil prices were curtailing any potential excitement from refining margins.

“The FTSE 100 ticked higher on Tuesday despite a weak update from index heavyweight BP acting as a drag on the market,” said AJ Bell investment director Russ Mould.

“A teaser ahead of second-quarter results later this month from BP suggests they won’t be a winner.

“The major issue is a big hit to refining margins, reflecting both market dynamics but also operational issues for the company. These factors also underpin guided impairments of $1 billion to $2 billion for the quarter. The broad range left the market with some uncertainty over how the second-quarter numbers will land.”

AIM movers: Strategic Minerals magnetite sales jump and Tavistock Investments ends partnership

2

Strategic Minerals (LON: SML) has more than trebled revenues from Cobre magnetite to $1.3m in the second quarter of 2024. First half sales are $2.1m and they should exceed $4m for the full year, up from the previous expectation of $3.5m. This could be the highest annual revenues since 2017 when they were $5.7m. The share price jumped by one-third to 0.2p.

An updates study of the Amapa iron ore project, where Cadence Minerals (LON: KDNC) owns 34.2%, shows process plant optimisation can be improved. The mine life of 15 years can have a throughput of 13Mt/year of iron ore. Cash cost is reduced to $33.50/t. The NPV10 for the project has increased by one-fifth to $1.1bn. The Cadence Minerals share price rose 29% to 4p.

Argentex (LON: AGFX) is trading in line in the first half of 2024. The financial and currency service provider recovered in the second quarter, but revenues dipped 4% to £23.9m. New management has been hired and the balance sheet is stronger following the recent fundraising. The share price recovered 15% to 31.05p.

Haydale Graphene (LON: HAYD) has signed a $4m contract with a Chinese tooling manufacturer which will distribute the company’s silicon carbide cutting tools. This is a minimum commitment for five years. The deal includes non-exclusive rights in two other territories. Haydale Graphene will be able to sell its partner’s product in the UK and US. The share price increased 6.78% to 0.315p.

FALLERS

Tavistock Investments (LON: TAVI) has terminated its ten-year strategic partnership with Titan Wealth Holdings because of a period of “unacceptable performance”. Tavistock Investments expects final sums due to be paid. The share price dipped 8.22% to 3.35p.

Biome Technologies (LON: BIOM) shares are still falling because of delays in orders at its bioplastics division and weaker demand in the coffee packaging market. Overall revenues will be well below expectations and a small loss is expected. Additional funding may be required. The share price slipped a further 6.25% to 37.5p, which is an all-time low.

Shares in Knights Group Holdings (LON: KGH) continue to decline following yesterday’s figures for the year to April 2024. Pre-tax profit improved from £11.5m to £14.8m and the total dividend raised to 4.4p/share. This year has started well with residential property business recovering. The share price declined 3.08% to 133.75p. This is still 20% higher than at the start of the year.  

Oil and gas producer Zephyr Energy (LON: ZPHR) has started the well production test on the State 36-2R LNW-CC well in the Paradox Basin in Utah. Initial results are encouraging. Over the next two weeks the data will be collected to estimate overall potential recoverable resources. The share price fell 2.06% to 4.75p.

Abingdon Health shares surge on 52% revenue growth, company ‘pleased’ with positive cash flow

Abingdon Health shares surged higher on Tuesday after the company announced an impressive 52% increase compared to the previous year.

Abingdon Health share price were 14.30% higher at the time of writing.

The firm’s growth trajectory is particularly noteworthy in the second half of FY 2024, with revenues surging 55% compared to the first half and 27% year-on-year. This robust performance has been driven by strong commercial progress across the group, with the contract services division seeing a 51% year-on-year revenue increase to £5.5 million.

Abingdon’s product division also contributed to the growth, with revenues of £0.7 million representing a 56% increase from the previous year. The launch of three Boots own-label tests in the second half of the year significantly boosted this segment’s performance.

In a positive turn for investors, Abingdon Health achieved cash flow positivity in the fourth quarter of 2024. The company ended the fiscal year with a cash balance of £1.3 million, demonstrating improved financial stability despite ongoing investments in growth.

“We are pleased to report another year of growing revenue performance with FY 2024 revenues 52% ahead of FY 2023,” said Chris Yates, CEO of Abingdon Health.

“We were particularly pleased to achieve positive cashflow in Q4 2024. Our key focus is to build a focused, high quality, sustainable, profitable business and we are making great strides towards this.  We believe with our lateral flow focus, our comprehensive CDMO service proposition and growing self-test distribution platform that we are well placed to deliver further revenue growth in FY 2025 and beyond.”

The acquisition of regulatory consultancy IVDeology in May 2024 has strengthened Abingdon’s service capabilities, particularly in the increasingly complex area of regulatory approval. This strategic move is expected to enhance the company’s ability to support customers navigating regulatory challenges in various markets.

Looking ahead, Abingdon’s board anticipates continued strong revenue growth in FY 2025. The company’s focus on building a sustainable, profitable business model appears to be gaining traction, with its comprehensive CDMO service proposition and growing self-test distribution platform positioning it well for future growth.

Argentex Group reports steady performance amid market challenges

Argentex Group PLC, the global specialist in currency risk management and alternative banking, expects to report revenues of approximately £23.9 million for the period, slightly down from £25.0 million in the same period last year as the company pursues overseas expansion.

Argentex Group shares were 7% higher at the time of writing.

Despite facing adverse market conditions in its core foreign exchange business during the first quarter, Argentex saw encouraging trading momentum in the second quarter. The Board remains confident in meeting full-year expectations, with the company continuing to trade in line with market projections.

The firm is making strides in its strategic focus areas, particularly in accelerating its Alternative Banking division and expanding its geographic footprint. Argentex has secured an Australian Financial Services Licence, a crucial step in its international growth strategy. The company is also progressing ahead of schedule in obtaining a regulatory licence in Dubai, signalling its commitment to global expansion.

“Following the completion of our strategic review at the start of the year we have made good progress as we begin to implement the key initiatives to transform the business into a leading provider of Alternative Banking solutions, which will complement our expertise in currency risk management, as outlined at the FY 2023 results,” said Jim Ormonde, CEO.

“We have invested in the people required to lead the transformation and develop the platforms needed to scale the business internationally and we now have a highly experienced leadership team in place to execute our growth agenda.

“Notwithstanding the fact that the period has been one of change as we reposition the business for growth and scalability, I am pleased with trading during the first six months of the year, in particular the accelerating momentum through Q2, and I remain confident in the full year outlook for the business.”

Vistry shares slip on profit-taking despite upbeat trading statement

Vistry is showing signs of life after the house builder said it expects profits to rise as its partnerships model leads outperformance compared with the rest of the sector.

After recently earning promotion to the FTSE 100, Vistry has hit the ground running releasing an upbeat trading statement highlighting improving demand and an expected 10% increase in adjusted operating profit for the full year.

Investors will be encouraged by the bullish outlook for completions as the company said it expected to deliver over 18,000 completions during the full year – a sharp jump from last year’s 16,118 completions.

Higher profits and completions guidance were underpinned by rising sales rates which hit 1.21 in the first half of 2024 compared to just 0.86 in the same period last year. 

“It has been a good week for builders following Labour’s election win and bold housing pledges. Vistry Group will look to reap the benefits as demand for affordable homes should see the firm’s profit rise around 7%,” said Adam Vettese, analyst at investment platform eToro.

“This is quite the turnaround from long-term material cost increases due to inflation, as well as a slow rate cutting cycle dampening the market for new home sales. Cost pressures are starting to ease and the first rate cut is likely just around the corner, so if the new government is true to its word it could be a great time to be in the housebuilding sector.”

Shares were slightly down on Tuesday after the stock embarked on a robust rally in the run-up to last week’s election.

The new Labour government’s approach to housebuilding will be highly supportive of Vistry’s business model and promise favourable outcomes for investors. The election victory was well-telegraphed by the polls, and investors bid the housebuilding sector up in the preceding weeks. However, the sector dipped in the wake of the election in a classic ‘buy the rumour, sell the fact trade’.

“A Labour government could provide a tailwind for Vistry compared to other traditional homebuilders. With promises of 300,000 houses annually, they are expected to release more land and offer taxation support, along with backing on planning, particularly for affordable housing,” said Yanmei Tang, Analyst at Third Bridge.